caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1932348406

Judie HowrylakM.D.

PRACTICETHE MILTON S HERSHEY MEDICAL CENTERSee all providers at this practice →
Pulmonary DiseaseHershey, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Judie Howrylak's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Carlos Jamis-Dow
Diagnostic Radiology · Sacramento, CA
2653
Robert Vender
Pulmonary Disease · Hershey, PA
2263
MAHRAJ, RICKHESVAR1731
Richard Bernstein
Pulmonary Disease · Hershey, PA
1629
Lauren Van Scoy
Pulmonary Disease · Hershey, PA
1220
Deborah Wolbrette
Clinical Cardiac Electrophysiology · Hershey, PA
1116
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
610
Unique beneficiaries
—
Total services
748
Distinct HCPCS
12
Medicare payment
$39K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 571 Pulmonary Disease providers in PA — above median (cohort median 707).
PRESCRIBING · PART D · 2024
Total Rx claims
1,521
Beneficiaries
—
Total drug cost
$3.8M
Distinct drugs
31
Brand share
44.6%
Top prescribed drugs
Azithromycin242 claims
Prednisone180 claims
Montelukast Sodium147 claims
Albuterol Sulfate143 claims
Elexacaftor/Tezacaftor/Ivacaft114 claims
QUALITY · MIPS · 2024
Final MIPS score
79.4
Quality
56.7
Cost
74.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.18%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.